Menopause-The Journal of the North American Menopause Society

Papers
(The TQCC of Menopause-The Journal of the North American Menopause Society is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Psychometric properties and validity of the Menopause Rating Scale in postmenopausal Portuguese women442
The effect of probiotic administration on the severity of menopausal symptoms and mental health of postmenopausal women: a triple-blind randomized controlled trial in the West of Iran120
Migraine and sleep quality: does the association change in midlife women?48
Reflecting on the enduring effects of childhood maltreatment30
Validation of the Menopause Transition Scale (MTS)23
Urban-rural differences in epidemiology and risk factors of menopause syndrome in middle-aged Chinese women20
Risk factors for delayed intrauterine device removal among menopausal women in rural China20
Dietary patterns and prevalence of multimorbidity in women in southern Brazil17
A call for health equity when addressing menopausal symptoms17
#Menopause: the menopause ontology project17
Health screening of middle-aged women: what factors impact longevity?17
Vitamin D supplements and prevalent overactive bladder in women from midlife through older ages15
Treating where it hurts: tailoring the genitourinary syndrome of menopause treatments15
Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis14
Association between vitamin D and calcium intakes, breast microcalcifications, breast tissue age-related lobular involution and breast density13
Low-serum anti-Müllerian hormone in middle-aged women associates with obesity markers13
Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors13
The prevalence of osteoporosis in postmenopausal women in urban Tianjin, China and its related factors12
The association of vasomotor symptoms during the menopausal transition and cognition in later life12
Perimenopause meets life: observations from the Women Living Better Survey12
Examining long-term health impacts of multiparity11
Risk factors for future osteoporosis in perimenopausal Japanese women11
The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study11
Lessons Learned in Clinical Research Recruitment of Midlife Latinas During COVID-1911
Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study11
Menopause hormone therapy and urinary symptoms: a systematic review11
Association of parity with body mass index and cardiometabolic risk in high-parous women10
Health care concerns in women at midlife: differences by race, ethnicity, and neighborhood socioeconomic status10
Cytological characteristics of premalignant cervical epithelial lesions in postmenopausal women based on endocrine indices and parakeratosis10
Impact of the CBT-Meno protocol on menopause-specific beliefs, dysfunctional attitudes, and coping behaviors9
Pharmacological interactions and menopausal hormone therapy: a review9
Exercise training and vascular function in postmenopausal individuals: a systematic review and meta-analysis9
Indian physicians' attitudes and practice regarding menopause and its management: a focus group discussion9
Risk of high depressive symptoms after the final menstrual period: the Study of Women’s Health Across the Nation (SWAN)9
Screening for factors at midlife associated with reduced longevity in women8
Network analysis of eating disorder symptoms in women in perimenopause and early postmenopause8
Psychometric evaluation of the German Day-to-Day Impact of Vaginal Aging questionnaire using data from two intervention studies8
Letters to the editor8
Perception of higher frequency of daily hot flashes in 50-year-old women today: a study of trends over time during 48 years in the Population Study of Women in Gothenburg, Sweden8
Isolated vitamin D supplementation improves the adipokine profile of postmenopausal women: a randomized clinical trial7
Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter?7
The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context7
Efficacy and safety of lemborexant in midlife women with insomnia disorder7
Menopause hormone therapy and sarcodynapenia: the Canadian Longitudinal Study on Aging7
Postmenopausal giant ovarian tumor: a rare case report and literature review7
Nonhormone treatments for vasomotor symptoms6
Does the addition of serum antimüllerian hormone concentrations to the Framingham Risk Score and Pooled Cohort Equations improve the prediction of cardiovascular disease?6
Genitourinary syndrome of menopause—I know it when I see it—or do I?6
Impact of vitamin D supplementation on modulating heat-shock proteins in postmenopausal women: a randomized, double-blind, placebo-controlled study6
Climacteric status is associated with sexual dysfunction at the age of 46 years: a population-based study6
Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis6
Hysterectomy with or without ovarian conservation: similar associations with vascular health?6
Menopause: The Journal of The North American Menopause Society Volume 29, 20226
Menopause for justice-involved women: consequences and care in prison systems6
Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea–based retrospective cohort study6
Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update6
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)5
Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers5
Update on estrogen therapy and prevention of bone loss5
The association between metabolic dysfunction–associated steatotic liver disease diagnosis and vasomotor symptoms in midlife women5
Hormone therapy and midlife sexuality—is estrogen a hormone of desire?5
Inflamm-aging or inflamm-opause: is inflammation the cause or consequence of vasomotor symptoms?5
Prasterone in the treatment of mild to moderate urge incontinence: an observational study5
Psychometric properties of a Persian version of the Vulvovaginal Symptoms Questionnaire for measuring vulvovaginal symptoms in postmenopausal women5
Uterine arcuate artery calcification as a potential marker of cardiovascular risk—a preliminary study5
Prophylactic salpingectomy with delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in BRCA1/2 mutation carriers: women's point of view5
Association of hormone preparations with bone mineral density, osteopenia, and osteoporosis in postmenopausal women: data from National Health and Nutrition Examination Survey 1999-20185
2022 Annual Meeting of The North American Menopause Society October 12 – 15, 2022, Atlanta, GA5
Should vitamin D supplements be prescribed routinely for midlife women?5
Interactions between nutrient intake and comorbidities for quality of life in premenopausal and postmenopausal women5
Moving toward health equity: the influence of race and ethnicity on choice and quality of life of menopause treatment in midlife women5
Trends in osteoporosis medication use in US postmenopausal women: analysis of the National Health and Nutrition Examination Survey 1999-2000 through 2017-20185
Associations of reproductive hormones and stress-related factors with menopausal symptoms5
0.83145904541016